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Members of
Several awards were presented prior to the business meeting. President Sharon Ellis introduced Pat Zenner, Regional Volunteer Advisor for the National Foundation of the March of Dimes, and conferred an honorary one-year membership for her interest in occupational health. Mrs. Zenner expressed her appreciation to Minnesota AOHN, and then Billing, Corresponding Secretary; Betty Richardson, Missouri AOHN President; Violet McVey, Director; Virginia Held, Director; Marie Weis, Program Chairman; Ray Sonnenberg, guest speaker; Ann Ducey, President; Mar ian Lempke, Director; Glenda Moore, Recording Secretary; Ann Carter, Director; and Daisy Metts , Treasurer. presented Mary Jo Sundberg, North American Life & Casualty Co., with a plaque from NFMD for outstanding service . She noted that Miss Sundberg was the first occupational health nurse to implement a company inservice occupational health service with NFMD. Mrs. Zenner also presented Certificates of Appreciation to Peg Anderson, Jan Driscoll, Val Gross and Margaret Hebrandson. NFMD logo pins were given to MAOHN President Sharon Ellis and AAOHN President Virainia L. Carlson.
ST. LOUIS AOHN NURSE-MANAGEMENT-PHYSICIAN BANQUET (from left) Joan
MINNESOTA'S SCHERING OCCUPA-TIONAL HEAL TH NURSE A WARD WIN-NER Ceil Raleigh (left) is congratulated by
Dan Carlson then presented the 1979 Schering Occupational Health Nurse Award to Ceil Raleigh, Burlington Northern. The inscription on the plaque read: "ln recognition for outstanding service to occupational health through exceptional day to day performance of professional responsibilities in all facets of this nursing specialty." A check for $120 was presented to the President to be used for ongoing educational programs.
The business meeting convened and the Tellers report was read. The officers for 1979-80 are: LaVonne Griffin, 3M Co., President; Audrienne Miller, Mayo Clinic, President-Elect; Jeanette Driscoll, Relief Nurse, Secretary; Mary Jane Hudoba, Tennant Co., Director; Elizabeth Magnuson, General Mills, Director; Charlene Moschkau, FMC Northern Ordinance Div., Director; and Fran Curran, 3M Co., Nominating Committee.
OHIO
The Gwinn Estate on the shores of Lake Erie in Bratenahl, a suburb of Cleveland, Ohio, was the scene of the Northeast OhloAOHN luncheon honoring its retirees on Saturday, June 9, 1979.
Among the thirty-six in attendance were twelve retirees: Helen Fakult, Blanche Grigas, Ruth Hall, Marie Kaval, Terressa McAdoo, Jane Nairn, Theresa O'Rourke, Mary Ellen Reifke, Vivian Sauvey, Mildred Taylor, Albina Tichar, and Elva Ulman.
A special memorial prayer was said in honor of Peg Stanton, a retiree who passed away soon after the celebration last year.
The business meeting following the luncheon, proved to be an informative, discussion-filled session. It opened with an introduction of each member. The retirees elaborated on their current activities. Most of them are quite active in volunteer work, hobbies, traveling and "just enjoying and living it up."
Hearty discussions of the various
REGIONAL
The 64th Annual Conference of the New England AOHN was held JuneS-10,1979, atthe Viking Hotel, Newport, Rhode Island.
General chairman of the conference was Helen Pasch, President of Rhode Island AOHN. She was assisted by June Patton, co-chairman and coordinator of scheduled events.
Approximately 233 members attended this conference with the theme "Smooth Sailing: Destination Health." On Friday, June 9, two concurrent sessions were held on "Cardiovascular Disease and the Workplace" and "Breast Self Examination Certification." Saturday, June 10, was a continuation of the BSE courses and a seminar on " A new trade package introduced June 4 contains five syringes, each filled with one .5 ml. dose of "Pneumovax."
The addition of the single-dose prefilled syringe to the existing package forms -single-dose and fivedose vials -gives doctors maximum flexibility and convenience in using the vaccine.
"Pneumovax," a polyvalent polysaccharide vaccine, is 90% effective against the 14 strains of bacteria causing over 80% of all pneumococcal pneumonia in the U.S.
The vaccine is recommended for use in people known to be at risk from pneumococcal pneumonia. Those at risk include persons with chronic heart, lung, and kidney diseases, and diabetes and other metabolic disorders; people in chronic care facilities; people convalescing from severe diseases; and people 50 years of age or older, especially those over 65. The vaccine should not be given to children under two years of age or during pregnancy.
The five single-dose prefilled syringes in the new trade package are individually carton ed, each with a direction circular and patient record sticker. The syringes carry the National Drug Code number 006-4670-38.
CROHN'S DISEASE
According to Abbott Laboratories, CG (cholyglycine) RIA is an effective test to determine CG serum bile acid measurements which aid in the differential diagnosis of Crohn's disease of the distal ileum.
More than 600,000 cases of Crohn's disease, an intestinal disorder associated 80-90% of the time with the distal ileum, are known to be in existence in the United States. Symptoms are usually severe but quite general and include pain in the stomach, loss of appetite and fever.
As Crohn's disease causes inflammation of the ileum, the active transport mechanism by which CG is transported from the intestine to the portal blood and back to the liver is altered. This causes a reduction in reabsorption of CG from the intestine.
The usual occurrence of a rise in the serum level of CG after a meal (post-prandially) is not seen in a patient with Crohn's disease. This is because as the ileal transport mechanism is compromised, the surge of bile acids through the enterohepatic cycle after eating is compromised and fecal loss of bile acids occurs. Therefore, if a fasting and 1-and 2hour post-prandial CG measurement is taken, it is possible to determine with a high degree of probability if Crohn's disease is present. Thus, CG RIA can be used in making a more positive diagnosis before using more invasive techniques, i.e., x-ray and biopsy of intestine.
This and other possible applications of RIA procedures comprised the subject matter of a recent symposium held in Chicago. Determinations of serum bile levels and serological markers in patients with liver and intestinal diseases were discussed. Michael Reese Hospital and Medical Center in cooperation with Abbott Laboratories Diagnostics Division presented this program which was entitled, "Clinical Significance of Serum Bile Acid Measurements in the Assessment of Patients with Liver and Intestinal Disease."
